FOSAPREPITANT vs FOSTAMATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSAPREPITANT vs FOSTAMATINIB: Safety Overview
| Metric | FOSAPREPITANT | FOSTAMATINIB |
|---|---|---|
| Total FAERS Reports | 487 | 6,394 |
| Deaths Reported | 154 | 453 |
| Death Rate | 31.6% | 7.1% |
| Hospitalizations | 264 | 1,493 |
| Average Patient Age | 49.6 yrs | 64.7 yrs |
| % Female Patients | 83.0% | 60.8% |
| FDA Approval Date | N/A | Apr 17, 2018 |
| Manufacturer | N/A | Rigel Pharmaceuticals, Inc. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |